Financial Wire

フォルトゥナ・マイニング社、ガイアナの石英岩プロジェクトに関する権益取得契約を締結

-- フォルトゥナ・マイニング(FVI.TO)は月曜日、ガイアナ中北部のクォーツストーン・プロジェクトに関して、ガイアナの民間企業Qstone社と権益取得契約を締結したと発表した。 この契約に基づき、フォルトゥナはクォーツストーン・プロジェクトの権益を最大70%まで取得できる可能性がある。 フォルトゥナは、4年以内に最低6万メートルの掘削を完了し、すべてのライセンス料と関連費用を負担することで、プロジェクトの権益を当初51%まで取得できる。最初のオプションを行使した場合、フォルトゥナはQstone社と合弁事業を設立する。 フォルトゥナは、最初のオプション行使後3年以内にフィージビリティスタディの費用を全額負担し、引き続きすべてのライセンス料を負担することで、プロジェクトの権益をさらに19%まで取得できる。 クォーツストーン・プロジェクトは、金生産量に対する国へのロイヤルティに加え、前所有者に有利な4.5%の製錬純収益ロイヤルティの対象となり、これは買い戻される可能性がある。 過去の掘削調査により、このプロジェクトでは地表付近に複数の高品位金鉱化帯が確認されています。 フォルトゥナ社の初期探査プログラムは、約550万米ドルの予算で、クォーツストーン鉱区で既に特定されている優先ターゲットの探査を進めるとともに、有望な26キロメートルに及ぶ主要剪断帯沿いの新たなターゲットの開拓に重点を置きます。

Related Articles

Australia

Arcus Biosciences Discontinues Phase 3 Lung Cancer Trial for Futility

Arcus Biosciences (RCUS) said Monday it discontinued its phase 3 STAR-121 study in metastatic non-small cell lung cancer after an Independent Data Monitoring Committee recommended stopping the trial for futility.The study, conducted in collaboration with Gilead Sciences (GILD), evaluated domvanalimab plus zimberelimab and chemotherapy versus pembrolizumab plus chemotherapy as a first-line treatment, the company said.The decision followed a pre-planned futility analysis indicating the treatment was unlikely to meet its primary endpoint.Shares of Arcus Biosciences were down 5% in Monday trading.Price: $23.05, Change: $-1.20, Percent Change: -4.95%

$GILD$RCUS
Australia

Sila Realty Trust to be Taken Private by Blue Owl Affiliates in $2.4 Billion Deal

Sila Realty Trust (SILA) agreed to be acquired and taken private by certain affiliates of Blue Owl Capital's (OWL) real estate unit in an all-cash deal worth roughly $2.4 billion.Shareholders of net lease real estate investment trust Sila will receive $30.38 per share, representing a 19% premium to the stock's closing price on Friday, the companies said Monday.The transaction, which requires approval from Sila's shareholders, is anticipated to complete in the second or third quarter of this year. Upon completion, the company will be delisted from the New York Stock Exchange."The consummation of this transaction will provide significant and immediate realized benefit to our shareholders," Sila Chief Executive Michael Seton said in a statement.Shares of Sila were up 19% in Monday trade. Asset manager Blue Owl rose 1%.Sila, which is focused on investing in healthcare facilities, said its portfolio comprised 137 real estate properties and three undeveloped land parcels in the US as of end-March. Data on its website showed its portfolio includes 86 medical outpatient buildings, 25 inpatient rehabilitation facilities, and 26 surgical and specialty facilities."This transaction provides us with a compelling opportunity to acquire a scaled portfolio with durable cash flows and attractive long-term growth characteristics, while further expanding Blue Owl managed funds' exposure to an asset class and sector we view as both resilient and essential given its critical role in both society and the economy," Marc Zahr, co-president and global head of real assets at Blue Owl, said.In February, Sila reported fourth-quarter adjusted funds from operations of $0.55 per share, up from $0.54 a year ago. Revenue rose to $50.7 million from $46.5 million.Sila plans to pay up to two regular quarterly dividends ahead of deal completion.Price: $30.44, Change: $+4.90, Percent Change: +19.19%

$OWL$SILA
Australia

Carnival Shareholders Approve Single Company Structure, Redomiciliation

Carnival (CCL, CUK) said Monday that majority of its shareholders approved the proposal to simplify its dual-listed structure into a single company and the redomiciliation of Carnival Corporation to Bermuda from Panama.The company said it expects the proposed changes to become effective on May 7.Price: $28.69, Change: $-0.53, Percent Change: -1.81%

$CCL$CUK